Request Deal Involvement
Laboratoires Théa to acquire sepofarsen and ultevursen assets from ProQR Therapeutics for €13m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Lazard
legal advisors
Allen & Overy
pr advisors
LifeSci Partners
pr advisors
FTI Consulting
legal advisors
Dentons
or
Principals
target
PROQR (SEPOFARSEN AND ULTEVURSEN)
vendor
ProQR THERAUPETICS
bidder
LABORATOIRES THEA
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite